Meet the Precision
AQ team at
World EPA Congress

Amsterdam, Netherlands | March 3-4, 2026

WEPA-2026

Precision AQ is a commercialization partner for biopharma innovators, market access teams, and brand strategists. Working with clients from all 30 of the world’s top pharma companies, we specialize in turning data chaos into commercial clarity. 

Global HEOR & Access Strategy team at World EPA Congress 2026

Whether it’s building the right evidence or refining your value story, we’re here to simplify the journey from development to patient care – so your therapies can reach the patients who need them most. 

Our International Access Consulting team supports global launch and commercialization strategies across diverse markets and regulatory landscapes, delivering tailored insights on value, pricing, reimbursement, and access dynamics that align evidence with the expectations of global decision makers. Our HEOR experts quantify value in ways that resonate with payers, providers, and policymakers by building models, analyses, and evidence frameworks that demonstrate clinical, economic, and societal impact. Together, these capabilities strengthen value narratives and equip teams for confident, evidence‑driven decision‑making.
 
Complete the form to book a meeting, and we’ll reach out to confirm the details. 


Meet Our Global HEOR & Access Strategy Team

AQ_GlobalAccess_AlexGrosvenor-3 AQ_GlobalAccess_AlexGrosvenor_bw-2

Alex Grosvenor

Eve Jamali-1 Eve Jamali-BW-1

Eve Jamali, MSc

AQ_GlobalAccess_RichardMacCaulay AQ_GlobalAccess_RichardMacCaulay_bw

Richard Macaulay, PhD

AQ_GlobalAccess_DavidCarr-1 AQ_GlobalAccess_DavidCarr_bw-1

David Carr, PhD

AQ_GlobalAccess_AkshitNayar AQ_GlobalAccess_AkshitNayar_bw

Akshit Nayar, MSc

Dominika Meszarosova_AQ_full-1 Dominika Meszarosova_AQ_full - Edited

Dominika Meszarosova, MSc

Walter Bouwmeester_AQ_full Walter Bouwmeester BW

Walter Bouwmeester, MSc

Chloi Theriou@AQ_full-1 Chloi Theriou BW-1

Chloi Theriou, MSc

Steeve Steeve.black and white

Steeve Lamontagne, MSc

Schedule a Meeting

Explore our blog

5 Takeaways from JPM That Will Shape 2026
Turning Clinical Breakthroughs Into Payer- Ready Value Stories
Delivering Real World Evidence That Matters to Payers: Insights from a Survey of Access Decision Makers